“细胞学样本中p53表达可能代表早期癌症的标志物”的勘误表。

IF 2.6 3区医学 Q3 ONCOLOGY

Cancer Cytopathology Pub Date : 2023-10-21 DOI:10.1002/cncy.22773

引用次数: 0

摘要

本勘误更正如下：Policardo F, Tralongo P, Arciuolo D, et al. 细胞学样本中 p53 的表达可能是早期癌症的标志物。Cancer Cytopathol.2023;131（6）：392-401.doi:10.1002/cncy.22694请注意，作者之一 Lina Cardisciani 的姓氏拼错为 "Cardasciani"。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Erratum to “p53 expression in cytology samples may represent a marker of early-stage cancer”

This erratum corrects the following:

Policardo F, Tralongo P, Arciuolo D, et al. p53 expression in cytology samples may represent a marker of early-stage cancer. Cancer Cytopathol. 2023;131(6):392-401. doi:10.1002/cncy.22694

Please note that the surname of one of the authors, Lina Cardisciani, was misspelled as “Cardasciani.”

The authors regret this error.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer Cytopathology 医学-病理学

CiteScore

7.00

自引率

17.60%

发文量

130

审稿时长

1 months

期刊介绍： Cancer Cytopathology provides a unique forum for interaction and dissemination of original research and educational information relevant to the practice of cytopathology and its related oncologic disciplines. The journal strives to have a positive effect on cancer prevention, early detection, diagnosis, and cure by the publication of high-quality content. The mission of Cancer Cytopathology is to present and inform readers of new applications, technological advances, cutting-edge research, novel applications of molecular techniques, and relevant review articles related to cytopathology.